Table 5.
Correlations between depressive symptoms and SLE clinical assessments.
| SLE subjects | ||||||
|---|---|---|---|---|---|---|
| (n = 73) | Pseudo R 2 | AICc | Coefficient | Odds ratio (95% CI) | p value | |
| Characteristics | ||||||
| Disease duration (years), mean ± SD | 17.81 ± 8.85 | 0.021 | 467.95 | 0.006 | 1.01 (1.00-1.02) | 0.211 |
| BMI, mean ± SD | 24.51 ± 5.60 | 0.103 | 461.59 | 0.021 | 1.02 (1.01–1.03) | 0.003 |
| Smoking, number (%) | ||||||
| Yes | 13 (18) | 0.032 | 467.14 | −0.186 | 0.83 (0.65–1.05) | 0.133 |
| Drinking, number (%) | ||||||
| Yes | 7 (10) | 0.006 | 469.03 | 0.100 | 1.11 (0.82–1.45) | 0.489 |
| Physical activity, number (%) | ||||||
| Yes | 24 (33) | 0.054 | 465.43 | −0.196 | 0.82 (0.68–0.99) | 0.047 |
| Laboratory | ||||||
| Sedimentation velocity, mean ± SD | 23.48 ± 20.96 | 0.355 | 440.12 | 0.003 | 1.00 (1.00-1.01) | 0.220 |
| C-reactive protein, mean ± SD | 0.44 ± 0.57 | 0.191 | 454.67 | 0.120 | 1.13 (0.97–1.29) | 0.094 |
| Leukocytes, mean ± SD | 6.73 ± 2.13 | 0.160 | 457.26 | −0.003 | 1.00 (0.96–1.04) | 0.884 |
| Brain leukocytes, mean ± SD | 6.22 ± 2.20 | 1.000 | 91.44 | 0.121 | 1.13 (1.04–1.23) | 0.005 |
| Lymphocytes, mean ± SD | 28.89 ± 8.09 | 0.160 | 457.27 | 0.001 | 1.00 (0.99–1.01) | 0.929 |
| Brain lymphocytes, mean ± SD | 29.05 ± 6.77 | 1.000 | 96.64 | −0.022 | 0.98 (0.95–1.01) | 0.117 |
| Anti-dsDNA, mean ± SD | 98.79 ± 111.01 | 0.829 | 370.64 | < 0.001 | 1.00 (1.00-1.00) | 0.990 |
| Brain anti-dsDNA, mean ± SD | 635.54 ± 1504.14 | 1.000 | 96.28 | < 0.001 | 1.00 (1.00-1.00) | 0.081 |